Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 103-108

  He, Lihua ^a   Yang, Xiaohong ^a   Cao, Xiaocheng ^a   Liu, Fei ^a   Quan, Meifang ^a   Cao, Jianguo ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Casticin; FOXM1; FOXO3a; Hepatocellular carcinoma

Indexed keywords

CASTICIN; CDC25B ANTIGEN; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FLAVONE DERIVATIVE; FOXM1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CD25B GENE; CDK1 GENE; CELL CYCLE ARREST; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; CYCLIN B GENE; DRUG MECHANISM; FLOW CYTOMETRY; FOXM1 GENE; FOXO3A GENE; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FLAVONOIDS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84872872078     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2076     Document Type: Article

References (37)

1. Purushotham AD, Lewison G and Sullivan R: The state of research and development in global cancer surgery. Ann Surg 255: 427-432, 2012.
2. Cao LQ, Chen XL, Wang Q, et al: Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells. Acta Pharmacol Sin 28: 879-887, 2007.
3. Zeng X, Fang Z, Wu Y and Zhang H: Chemical constituents of the fruits of Vitex trifolia L. Zhongguo Zhong Yao Za Zhi 21: 167-168, 191, 1996 (In Chinese).
4. Haidara K, Zamir L, Shi QW and Batist G: The flavonoid casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett 242: 180-190, 2006.
5. Wojcinski S, Farrokh A, Hille U, et al: The Automated Breast Volume Scanner (ABVS): initial experiences in lesion detection compared with conventional handheld B-mode ultrasound: a pilot study of 50 cases. Int J Womens Health 3: 337-346, 2011.
6. Zeng F, Tian L, Liu F, Cao J, Quan M and Sheng X: Induction of apoptosis by casticin in cervical cancer cells: reactive oxygen species-dependent sustained activation of Jun N-terminal kinase. Acta Biochim Biophys Sin (Shanghai) 44: 442-449, 2012.
7. Csupor-Loffler B, Hajdu Z, Zupko I, et al: Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s. l. on cultured human tumour cell lines. Phytother Res 23: 672-676, 2009.
8. Kobayakawa J, Sato-Nishimori F, Moriyasu M and Matsukawa Y: G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil. ). Cancer Lett 208: 59-64, 2004.
9. Imai M, Kikuchi H, Denda T, Ohyama K, Hirobe C and Toyoda H: Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance. Cancer Lett 276: 74-80, 2009.
10. Yang J, Yang Y, Tian L, Sheng XF, Liu F and Cao JG: Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells. World J Gastroenterol 17: 4298-4307, 2011.
11. Galili N, Davis RJ, Fredericks WJ, et al: Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5: 230-235, 1993.
12. Anderson MJ, Viars CS, Czekay S, Cavenee WK and Arden KC: Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47: 187-199, 1998.
13. Guo S, Rena G, Cichy S, He X, Cohen P and Unterman T: Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 274: 17184-17192, 1999.
14. Medema RH, Kops GJ, Bos JL and Burgering BM: AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787, 2000.
15. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M and Sellers WR: Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20: 8969-8982, 2000.
16. Lu M, Ma J, Xue W, et al: The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma. Pathol Oncol Res 15: 679-687, 2009.
17. Fei M, Lu M, Wang Y, et al: Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization. Med Oncol 26: 178-185, 2009.
18. Myatt SS and Lam EW: The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7: 847-859, 2007.
19. Park TJ, Kim JY, Oh SP, et al: TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop. Hepatology 47: 1533-1543, 2008.
20. Wang Z, Ahmad A, Li Y, Banerjee S, Kong D and Sarkar FH: Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev 36: 151-156, 2010.
21. Zhao XC, Tian L, Cao JG and Liu F: Induction of apoptosis by 5,7-dihydroxy-8-nitrochrysin in breast cancer cells: the role of reactive oxygen species and Akt. Int J Oncol 37: 1345-1352, 2010.
22. Yang XH, Zheng X, Cao JG, Xiang HL, Liu F and Lv Y: 8-Bromo-7- methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol 16: 3385-3393, 2010.
23. Wu QF, Liu C, Tai MH, et al: Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro. Acta Pharmacol Sin 31: 361-366, 2010.
24. Shankar S, Chen Q and Srivastava RK: Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J Mol Signal 3: 7, 2008.
25. Laoukili J, Stahl M and Medema RH: FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 1775: 92-102, 2007.
26. Krupczak-Hollis K, Wang X, Kalinichenko VV, et al: The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev Biol 276: 74-88, 2004.
27. Wonsey DR and Follettie MT: Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 65: 5181-5189, 2005.
28. Laoukili J, Kooistra MR, Bras A, et al: FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7: 126-136, 2005.
29. Zeng J, Wang L, Li Q, et al: FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol 218: 419-427, 2009.
30. Liu M, Dai B, Kang SH, et al: FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66: 3593-3602, 2006.
31. Korver W, Roose J and Clevers H: The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res 25: 1715-1719, 1997.
32. Calvisi DF, Pinna F, Ladu S, et al: Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut 58: 679-687, 2009.
33. Yilmaz OH and Morrison SJ: The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells. Blood Cells Mol Dis 41: 73-76, 2008.
34. Han CY, Cho KB, Choi HS, Han HK and Kang KW: Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells. Carcinogenesis 29: 1837-1844, 2008.
35. Fu Z and Tindall DJ: FOXOs, cancer and regulation of apoptosis. Oncogene 27: 2312-2319, 2008.
36. Fernandez de Mattos S, Villalonga P, Clardy J and Lam EW: FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther 7: 3237-3246, 2008.
37. Sunters A, Fernandez de Mattos S, Stahl M, et al: FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278: 49795-49805, 2003.